Having a second autoimmune disease alongside multiple sclerosis (MS) does not accelerate disability progression, according to ...
MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II ...
MedPage Today on MSN
Vision-Threatening Forms of Diabetic Retinal Disease Have Plummeted
Better diabetes medications, better screening, older age at onset of DRD influence 20-year ...
Anti-CD20 therapies and S1P receptor modulators seem to be equally effective for most people with late-onset MS, a real-world ...
Low-grade systemic inflammation (hsCRP 2–10 mg/L) stratified risk beyond comorbidities and medications in both CKD+ASCVD and ...
MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas ...
Swap overcomplicated routines for a simple, structured framework you can sustain long-term ...
This guide explains what a genuinely natural result requires, why most before-and-after photographs do not tell the full ...
Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...
Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.
This is about work—mastering the craft of the most important position in sports as the quarterback landscape has only become ...
Positive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) indicates a statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results